IPP Bureau
Cosette Pharmaceuticals acquires Intrarosa from Endoceutics
By IPP Bureau - June 09, 2023
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
Lantern Pharma leverages AI platform to develop breakthrough ADCs with Bielefeld University
By IPP Bureau - June 09, 2023
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Health Ministry organizes webinar on Non-Alcoholic Fatty Liver Diseases
By IPP Bureau - June 09, 2023
Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level
Zydus receives final approval from USFDA for Esomeprazole Magnesium
By IPP Bureau - June 09, 2023
Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023)
Ecolab expands biologics resin manufacturing facility in Pennsylvania
By IPP Bureau - June 09, 2023
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
Lonza signs VPPA for solar power supply with Ignis
By IPP Bureau - June 09, 2023
Under the terms of the VPPA, IGNIS will produce renewable energy equal to Lonza’s electricity needs across Switzerland and the European Union.
Croda breaks ground on lipid manufacturing facility in Pennsylvania
By IPP Bureau - June 09, 2023
Construction will begin this year with the new capacity anticipated by 2025
Venus Remedies receives Ukrainian GMP approval for Its Carbapenem, Oncology parenteral facilities
By IPP Bureau - June 08, 2023
The company expects this approval in Baddi to pave the way for GMP certifications from European Medicines Agency and other PIC/S member nations
Zydus receives final approval from the USFDA for Tadalafil Tablets USP
By IPP Bureau - June 08, 2023
Tadalafil Tablets USP, 20 mg had annual sales of USD 61 mn in the United States (IQVIA MAT April 2023)
Coveris opens new recover recycling facility with pioneering technology
By IPP Bureau - June 08, 2023
The new recycling facility, Recover Louth, is the second addition to Coveris’ closed loop recycling business segment
European Commission authorises GSK’s Arexvy for older adults
By IPP Bureau - June 08, 2023
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
Bayer partners with biotech firm on lipid nanoparticle delivery systems
By IPP Bureau - June 08, 2023
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
JB Pharma completes 1 year of its identity launch
By IPP Bureau - June 07, 2023
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
Brinton appoints Amit Jain as President & Head of Domestic Business
By IPP Bureau - June 07, 2023
Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing
BASF and Merck KGaA introduce a new standard for electronic exchange of quality and regulatory data
By IPP Bureau - June 07, 2023
The collaboration focuses on the development and sharing of Standard Quality and Regulatory Documentation (StaQRD), a standard guide for the electronic transfer of information
